BIO-key Receives Notice of Non-Compliance from Nasdaq Related to Delay of its Form 10-K Filing
HOLMDEL, N.J., April 22, 2026 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (Nasdaq: BKYI),…
Alzai Health Corp. Files Final Prospectus in Connection With Initial Public Offering
April 22, 2026 16:17 ET | Source: Alzai Health Corp. Not for…
SkinHealth Systems Inc. Appoints Three New Independent Directors to Board
Kenneth Tripp, Dr. Sachin Shridharani, and E. Scott Beattie bring deep expertise…
TOMI Environmental Solutions Scales Automation with SteraMist iHP Robot Upgrade; Targets Fast Growing Robotaxi Market
Pairing Decontamination Versatility with Domestic Lithium Power to Meet the Global Demand…
Abivax to Present Data on Obefazimod at Digestive Disease Week
Abivax to Present Data on Obefazimod at Digestive Disease Week® Presentations Highlight…
Kyverna Presents Registrational Trial Primary Analysis for Miv-cel in Stiff Person Syndrome Demonstrating Statistically Significant, Durable Clinical Benefit Across All Endpoints in an Oral, Late-Breaker Session at AAN Annual Meeting
Single-dose of miv-cel achieved robust and durable improvements in mobility, reversed disability…
RNK Health NAD+ Longevity Therapy Claims Evaluated: The Clinician-Guided NAD Injections & Medication Protocol
Des Moines, IA, April 21, 2026 (GLOBE NEWSWIRE) -- The information below…
Revolution Medicines to Present Updated Phase 1/2 Clinical Data for Daraxonrasib in First Line Metastatic Pancreatic Cancer Across Monotherapy and Combination Cohorts at the 2026 AACR Annual Meeting
REDWOOD CITY, Calif., April 21, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc.…
AvePoint to Announce First Quarter 2026 Financial Results on May 7
JERSEY CITY, N.J., April 21, 2026 (GLOBE NEWSWIRE) -- AvePoint (Nasdaq: AVPT; SGX:…
NewHydrogen Completes Critical Pre-Pilot Plant Technical Validation
The Company greenlights construction of a ThermoLoop engineering test unit to define…
